Saralasin acetate

This classification denotes an antihypertensive agent with the molecular formula C42H65N13O10.C2H4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FO21Z580M4. The term saralasin acetate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule saralasin acetate under HS 29371900 and SITC 54154. As of Q4 2014, SARALASIN ACETATE remains US FDA's Preferred Term for this commodity. Saralasin acetate bears US NLM identifiers UMLS ID C0030114 and NCI Concept Code C66528. SMILES: C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2C[NH]CN2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3CCC(CC3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC.CC(=O)O.O.